Figures
- FIGURE 1
Satisfaction with change to video/phone consultations. A change to video/phone consultations was reported by 212 patients, of whom 207 indicated their satisfaction level with this change.
- FIGURE 2
Satisfaction with change to home-administered biologics. Satisfaction with change to home-administered biologics in patients reporting this change in their biologic care (n=153).
- FIGURE 3
Physicians’ expected changes to future severe asthma care. Physicians’ beliefs about how asthma care will change following the pandemic (n=268).
Tables
- TABLE 1
Country breakdown of physician and patient respondents to questionnaires
Country Physicians n Patients n Female
n (%)Use of biologics
n (%)Daily OCS
n (%)Belgium 13 102 57 (56) 86 (84) 9 (9) Estonia 8 14 13 (93) 6 (43) 5 (36) France 28 15 10 (67) 13 (87) 5 (33) Greece 18 122 82 (67) 74 (60) 35 (29) Hungary 40 110 71 (65) 71 (65) 22 (20) Italy 31 52 38 (73) 28 (54) 13 (25) Latvia 4 54 33 (61) 24 (44) 19 (35) Lithuania 15 53 35 (66) 41 (77) 8 (15) The Netherlands 2 114 69 (61) 79 (69) 27 (24) Romania 31 12 5 (42) 9 (75) 3 (25) Russian Federation 13 55 34 (62) 11 (20) 9 (16) Serbia 15 74 50 (68) 45 (60) 30 (41) Slovenia 2 70 51 (73) 64 (91) 12 (17) Sweden 9 122 60 (49) 67 (55) 34 (28) Switzerland 19 57 25 (44) 46 (81) 19 (33) UK 20 75 43 (57) 45 (60) 31 (41) Total 268 1101 676 (61) 709 (64) 281 (26) Number of returned physician surveys per country, and number and characteristics of participating patients per country. OCS: oral corticosteroids.
- TABLE 2
Physician-reported changes in delivery of care
Change in care n (%) Reorganisation of care by physicians (i.e. voluntary) Change to video/phone consultations 122 (46) Outpatient clinic continued with social distancing 142 (53) Urgent consultations only 44 (16) New patients postponed 32 (12) Switch to home-administered biologics 102 (38) Changes induced by the pandemic (i.e. involuntary) Reduced capacity outpatient clinic 109 (41) Reduced capacity lung function lab 159 (59) Fewer physicians available 115 (43) Fewer nurses available 76 (28) Changes in severe asthma care during the coronavirus disease 2019 (COVID-19) pandemic as reported by the participating severe asthma specialists (n=268).
- TABLE 3
Satisfaction scores with types of change in care and asthma control
n (%) Satisfaction with care Satisfaction with changes in care Effect on asthma control attributed to changes in care All patients (n=1101) No change 607 (55) 4.42±0.61# Change 494 (45) 3.85±0.72# 3.68±0.93 1.90±0.84 Type of change reported (n=467) Phone/video consultations 212 (45) 3.96±0.67 3.81±0.87 1.80±0.78 Monitored my asthma at home 24 (5) 3.55±0.76 3.65±0.86 2.24±0.70 The location of my appointments was changed 43 (9) 3.90±0.68 3.78±0.91 1.86±0.87 Attended alternative unit (e.g. ED) 10 (2) 3.66±0.92 3.55±1.28 2.50±1.25 I chose to cancel appointments 61 (13) 3.60±0.74 3.30±1.00 2.07±0.96 Cancelled or postponed by clinic 117 (25) 3.79±0.74 3.55±0.97 1.91±0.85 Data presented as mean±sd, unless otherwise stated. Patient-reported changes in severe asthma care during the coronavirus disease 2019 (COVID-19) pandemic and associated levels of satisfaction with care and changes in care, and patient-perceived effect on asthma control. Higher satisfaction scores indicate better satisfaction (range 1–5, 1=very low satisfaction and 5=very high satisfaction); higher asthma control scores indicate greater agreement with statements that changes in care induced worsening of asthma control (range 1–5, 1=strongly disagree and 5=strongly agree). ED: emergency department. #: t (1068)=15.82, p<0.001, d=0.96.
- TABLE 4
Satisfaction scores with types of change in biologic care and asthma control
n (%) Satisfaction with care Satisfaction with changes in care Effect on asthma control attributed to changes in biologic treatment All patients on biologics (n=709) No change 542 (76) 4.40±0.59# Change 167 (24) 3.93±0.68# 3.72±1.08 1.90±0.88 Type of change reported (n=167) Switch to home administration 153 (92) 3.96±0.67 3.90±0.87 1.76±0.74 Treatment less frequent 4 (2) 4.05±0.46 3.83±0.53 2.22±1.57 Treatment postponed 7 (4) 3.63±0.84 3.92±1.02 2.05±0.83 Treatment stopped 3 (2) 3.04±0.33 3.17±0.29 3.22±0.69 Data presented as mean±sd, unless otherwise stated. Patient-reported changes in biologic care during the coronavirus disease 2019 (COVID-19) pandemic and associated levels of satisfaction with care and changes in care, and patient-perceived effect on asthma control. Higher satisfaction scores indicate better satisfaction (range 1–5, 1=very low satisfaction and 5=very high satisfaction); higher asthma control scores indicate greater agreement with a statement that changes in biologic care induced worsening of asthma control (range 1–5, 1=strongly disagree and 5=strongly agree). Data of 709 patients on biologics; 26 did not complete the questions concerning satisfaction with care. #: t (674)=8.47, p<0.001, d=0.72.
Supplementary Material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Guidance for Reporting Involvement of Patients and the Public (GRIPP)-2 form 00065-2022.SUPPLEMENT
Patient survey 00065-2022.SUPPLEMENT2
Physician survey 00065-2022.SUPPLEMENT3
